1193244-87-9 Usage
Uses
Used in Pharmaceutical Synthesis:
Methyl 5-iodo-1-methyl-1H-pyrazole-3-carboxylate is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure and reactivity allow for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Synthesis:
In the agrochemical industry, methyl 5-iodo-1-methyl-1H-pyrazole-3-carboxylate serves as an essential intermediate for the synthesis of various agrochemicals. Its incorporation into these products can lead to the development of more effective and targeted pest control solutions.
Used in Organic Synthesis:
Methyl 5-iodo-1-methyl-1H-pyrazole-3-carboxylate is utilized as a versatile intermediate in organic synthesis, enabling the creation of a wide range of chemical products. Its unique properties facilitate the synthesis of complex organic molecules for various applications, including the development of new materials and compounds with specific functionalities.
Check Digit Verification of cas no
The CAS Registry Mumber 1193244-87-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,3,2,4 and 4 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1193244-87:
(9*1)+(8*1)+(7*9)+(6*3)+(5*2)+(4*4)+(3*4)+(2*8)+(1*7)=159
159 % 10 = 9
So 1193244-87-9 is a valid CAS Registry Number.
1193244-87-9Relevant academic research and scientific papers
DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES
-
Page/Page column 39; 83-84, (2020/01/24)
The application describes dihydropyrimidine derivatives which are useful in the treatment or prevention of HBV infection or of HBV-induced diseases, more particularly of HBV chronic infection or of diseases induced by HBV chronic infection, as well as pharmaceutical or medical applications thereof.
NOVEL PYRAZOLE-3-CARBOXAMIDE DERIVATIVE HAVING 5-HT2B RECEPTOR ANTAGONIST ACTIVITY
-
, (2011/11/13)
Disclosed is a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof, which is useful as a selective antagonist of a 5-HT2B receptor. The compound and salt are useful for treatment or prevention of various diseases and conditions associated with a 5-HT2B receptor.
